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Objectives: To analyze the conditions of psychological dysfunction and positive mental health
in patients with asthma and chronic bronchitis (CB), as compared to healthy individuals, and to
identify the factors associated with these mental health indicators.
Methods: Cross-sectional study based on data obtained from the European Health Interview
Survey for Spain (EHISS, 2009). We identified individuals with asthma and CB using a specific
questionnaire. In order to assess mental health, two indicators extracted from questionnaire
SF-36 were used: psychological dysfunction and positive mental health status.
Results: Out of 19,598 subjects included in the study, 8.3% were classified as asthmatic and
7.4% as CB. Healthy individuals had significantly higher psychological dysfunction scores than
those with asthma and CB. The same occurred with positive mental health. The variables inde-
pendently associated with lower scores out of these variables were gender female, a greater
number of chronic diseases and obesity. On the contrary, alcohol consumption and physical
exercise were associated with a higher score in the aforementioned variables.
Conclusions: Healthy individuals have significantly higher scores in psychological dysfunction
and positive mental health than patients with asthma and CB. This suggests that their mental
health is much better. The variables related with lower scores out of these variables, and
therefore with worse mental health, are: being female, having a greater number of chronic
diseases and obesity. On the contrary, alcohol consumption and the practicing of physical exer-
cise are associated with a higher score in the aforementioned variables, thus indicating
a greater degree of mental health.
ª 2012 Elsevier Ltd. All rights reserved.27 369 169.
lud.madrid.org (J. de Miguel Diez).
2 Elsevier Ltd. All rights reserved.
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European Union (EU) Member States in order to createAsthma and chronic obstructive pulmonary disease (COPD)
are two of the most significant respiratory problems today.
Their prevalence in our country is high; with numbers
ranging from 1 to 15% of the population for asthma1,2 and
around 10% for COPD in adult individuals aged 40e80.3
Psychiatric disorders, including anxiety and depression,
are common among these patients; however, they
frequently go undetected. Among patients with asthma,
prevalence rates for anxiety ranging from 16 to 52% and
depression from 14 to 41% have been observed.4e10 On the
other hand, among COPD patients, depression symptoms
have been identified in 16e74% of cases11e14, and the
existence of anxiety has been detected in 2e96% of
patients.15e17 Discrepancies between the results obtained
in different studies may be due to various factors, including
methodological variations and differences in the criteria
used to establish the diagnosis of these psychiatric
diseases. Furthermore, many of the studies that have
investigated this association have been performed based on
clinical or convenience samples, thus limiting the conclu-
sions that could be drawn in regard to the generalization of
the results. Therefore, the impact of psychological disor-
ders is not well described in terms of the health of the
population with asthma and COPD. In this sense, in two
recent population-based studies performed by our group,
the prevalence numbers for depression and anxiety among
patients with asthma were shown to be 9% and 9.7%,
respectively,18 and in patients with chronic bronchitis, they
were 15.9% and 9.4%, respectively.19
The presence of psychiatric diseases in patients with
asthma and COPD is associated with a worse prognosis and
contributes to an increase in the use of health resources
and the costs associated with the treatment of both dis-
eases.11,16e22 Thus, the detection of depression and anxiety
is very important in patients with obstructive airway
diseases. This has led to the establishment of certain
recommendations for their systematic detection in these
patients, as a part of their clinical examinations.
In literature, various screening tests and diagnosis tools
have been used to assess the existence of depression and
anxiety. However, in order to identify the presence of these
psychiatric disorders on a clinical level, structured inter-
views should be performed, thus making their application
difficult in population-based studies. Certain authors have
resorted to the generic SF-36 quality of life questionnaire in
order to differentiate between patients with and without
psychological disorders.23
The main objectives of the present study were, on the
one hand, to analyze the conditions of psychological
dysfunction and positive mental health in patients with
asthma and COPD, when compared to healthy individuals
and, on the other hand, to identify the factors associated
with these mental health indicators.
Methods
The present study is a cross-sectional study based on data
obtained from the European Health Interview Survey for
Spain (EHISS, 2009). The European Health Interview Survey(EHIS) was proposed by the European Commission to the
a health information system using a comprehensive and
coordinated set of surveys performed within the European
Statistical System under the responsibility of Eurostat.
Therefore, all EU States would share common guidelines for
the survey modules (Health determinants, Health status,
Health care, Background variables) and design, and be
based on a common questionnaire. The EHIS is to be
implemented every five years with the first wave
completed between 2007 and 2009.24
The European Health Interview Survey for Spain (EHISS,
2009) was conducted by the National Statistics Institute
(Instituto Nacional de Estadı´stica, INE) under the aegis of
the Spanish Ministry of Health & Social Affairs. The EHISS is
a computer-aided home-based personal interview exam-
ining a nationwide representative sample of the civilian,
non-institutionalized population, aged 16 years or over and
residing in primary family dwellings (households) in Spain.
Study subjects were selected by means of probabilistic
multistage sampling, with the first-stage units being census
sections, and the second-stage units being primary family
dwellings. More details of EHISS methodology are described
elsewhere.25 The data collection period began in April 2009
and ended in March 2010. The analysis was performed in
January 2011.
For study purposes, subjects aged 18 years and over
were selected. We identified individuals suffering from
asthma as those that answered “yes” to both of the
following questions, “Have you suffered from asthma over
the previous 12 months?” and “Has your medical doctor
confirmed the diagnosis of asthma?”. We identified indi-
viduals suffering from chronic bronchitis as those that
answered “yes” to the question, “Has your doctor told you
that you are currently suffering from chronic bronchitis?”.
The presence of depression or anxiety was assessed using
the following questions: 1) “Have you suffered from
depression or anxiety over the previous 12 months? 2) “Has
your medical doctor confirmed the diagnosis?” 3) “Have you
consumed antidepressants prescribed by your physician
over the last two weeks?” and, 4) “Have you consumed
anxiolytics prescribed by your physician over the last two
weeks?” Those who answered yes to questions 1, 2 and 3 or
to all the questions were considered “Depression
sufferers”, and those who answered yes to questions 1, 2
and 4 were considered “Anxiety sufferers”.
In order to assess mental health, two indicators extracted
from the SF-36 quality of life questionnaire were used:
psychological dysfunction and positive mental health state.
Both indicators are obtained through 9 items and are scored
from 0 to 100, where 100 represents optimal mental health.26
The following were analyzed as independent variables:
1) socio-demographic characteristics (i.e. sex, age); 2)
heath-related variables; including, number of diagnosed
concomitant chronic diseases and lifestyle-related habits.
We considered as comorbidity the self-reported, medi-
cally-diagnosed presence of any of the following associated
chronic diseases: diabetes, high blood pressure, chronic
bronchitis, heart disease, myocardial infarction, cancer
and stroke. We analyzed the number of comorbid diseases
in three categories, namely: “None”, “One or two” and
“Three or more”.
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between current/ex-smokers and non-smokers. Alcohol
consumption was measured using the question, “Have you
consumed any alcoholic drinks during the last two weeks?”.
“No physical exercise” was deemed to apply to cases where
the individuals in question acknowledged doing no physical
activity in their free time.
Finally, the body mass index (BMI) was calculated from
the self-reported body weight and height. Individuals with
a BMI  30 were classified as obese.
Statistical analysis
Firstly, the distribution according to the study variables was
described and compared for the individuals with andwithout
asthma or chronic bronchitis and healthy individuals.
Secondly, we estimated the prevalence, with a 95%
confidence interval of depression and anxiety for adults
with and without asthma or chronic bronchitis and health
adults, according to the study variables.
Thirdly, we analyzed the mean scores for psychological
dysfunction using socio-demographic characteristics and
lifestyle variables among adults with and without asthma or
chronic bronchitis and healthy adults.
Finally, to assess variables associated with psychological
dysfunction and positive mental health among adults
suffering from asthma or chronic bronchitis, we conducted
a multivariate lineal regression model.
Bivariate comparison of proportions was made using the
“chi-square test”. The multivariate lineal regression anal-
ysis was performed including variables that were statisti-
cally significant in the bivariate analysis and variables,
which, although they did not achieve statistical signifi-
cance, were of interest from epidemiological and health
care viewpoints. Variables were eliminated, one at each
step, according to their significance in the model used and
considering the model’s goodness-of-fit in terms of the
previous step. The effects of possible interaction among
the variables included in the final model were also exam-
ined. The interaction terms tested included, among others,
sex and age with tobacco and alcohol use and obesity. Also
the interactions of the chronic conditions studied with
unhealthy lifestyles and study variables measuring mental
health were tested.
Estimates were made using the STATA program and
statistical significance was set as two-tailed a < 0.05.
As this investigation was conducted using de-identified
public-use databases, it was not necessary to have the
approval of an ethics committee, as per Spanish legislation.
Results
22,697 individuals were eligible for this study. Table 1 shows
the socio-demographic characteristics and lifestyle vari-
ables among adult subjects (aged 18) with and without
asthma or chronic bronchitis and health adults included in
the 2009 European Health Interview Survey for Spain.
Asthmatic individuals were more frequently men and
their age was significantly higher than that of healthy
subjects. Additionally, patients with asthma presented
a greater number of comorbid chronic diseases. On theother hand, the prevalence of smoking, alcohol consump-
tion and physical exercise were significantly lower among
adults with asthma, in comparison with healthy individuals,
while the prevalence of obesity was greater.
Adults suffering from chronic bronchitis were signifi-
cantly older than healthy subjects. Furthermore, they
suffered from a greater number of comorbid chronic
diseases. On the other hand, the prevalence of ex-smokers
was significantly lower among the adults with chronic
bronchitis, in comparison with healthy individuals, while
the prevalence of obesity was comparatively greater.
Table 2 show the prevalence of depression among
Spanish adults (age 18 years) with or without asthma or
chronic bronchitis and in healthy individuals, according to
the study variables. The prevalence of anxiety by socio-
demographic characteristics and lifestyle variables among
adults (18 years) with and without asthma or chronic
bronchitis, and healthy individuals included in the 2009
European Health Interview Survey for Spain are detailed in
Supplementary Table 2. Generally speaking, prevalence
numbers were significantly lower in healthy individuals,
when compared to those with asthma or chronic bronchitis.
Table 3 show the average scores obtained in the variable
“Positive mental health” by socio-demographic character-
istics and lifestyle variables among adults (18 years) with
and without asthma or chronic bronchitis and healthy
adults included in the 2009 European Health Interview
Survey for Spain. The mean scores in “Psychological
dysfunction” are detailed in Supplementary Table 3.
Healthy individuals had significantly higher psychological
dysfunction scores (75.8; 95% CI: 75.5e76.1) than those
with asthma (70.8; 95% CI: 69.8e71.8) and chronic bron-
chitis (67.4; 95% CI: 66.4e68.5). The same occurred with
positive mental health, the average score being signifi-
cantly higher among healthy subjects (67.3%; 95% CI:
67.0e67.6) than those with asthma (60.3; 95% CI:
59.3e61.3) and in patients with chronic bronchitis (55.7;
95% CI: 54.6e56.8).
Study participants with depression had a mean score for
psychological dysfunction of 44.16 (SD 22.46) and positive
mental health mean score of 37.42 (SD 23.13). Subjects
with anxiety had psychological dysfunction mean score of
48.45 (SD 23,43) and a positive mental health mean score of
42.38 (SD 24.36) Subjects without depression or anxiety had
psychological dysfunction mean score of 76.91 (SD 18.77)
and a positive mental health mean score of 68.05 (SD
21.09). Persons suffering either depression or anxiety had
significantly lower scores than healthy subjects (p < 0.001).
Variables associated in an independent manner with
mental health indicators, namely, “Psychological dysfunc-
tion” and “Positive mental health”, in adults with asthma
or chronic bronchitis, both overall and by gender, are
shown in Table 4. In regard to asthma, variables that were
independently and significantly associated with a lower
score (and therefore, worse mental health) in “Psycholog-
ical dysfunction” were: being female, having a greater
number of chronic diseases and having a higher BMI,
whereas physical exercise was associated with a higher
score (indicating better mental health) in this variable.
Similar results were obtained for the “Positive mental
health” component in subjects with asthma. Additionally,
in this case, both age (more advanced ages were associated
Table 1 Socio-demographic characteristics and lifestyle variables among adults (18 years) with and without asthma or
chronic bronchitis, and healthy individuals included in the 2009 European Health Interview Survey for Spain.
Variable Categories Asthma N Z 1632 Chronic bronchitis
N Z 1467
Health N Z 19,598
Sexa Female 61.5 (59.1e63.8) 52.8 (50.2e55.3) 54.4 (53.7e55.1)
Male 38.4 (36.1e40.8) 47.1 (44.6e49.7) 45.5 (44.8e46.2)
Agea,b 18e49 52.1 (49.6e54.5) 25.3 (23.1e27.6) 50.3 (15.2e16.2)
50e59 years 11.8 (10.3e13.5) 12.8 (11.2e14.6) 15.7 (15.2e16.2)
60e69 years 13.0 (11.4e14.7) 19.5 (17.5e21.6) 14.0 (13.5e14.5)
70 years 23.0 (21.0e25.2) 42.2 (39.7e44.8) 19.9 (19.4e20.5)
Number of chronic conditionsa,b None 49.4 (47.0e51.8) 29.1 (26.8e31.4) 70.0 (69.3e70.6)
1e2 40.8 (38.4e43.2) 56.8 (54.3e59.3) 27.6 (27.0e28.3)
3 9.7 (8.4e11.2) 14.0 (12.3e15.9) 2.3 (2.1e2.5)
Smoking habita,b Smoker 24.5 (22.4e26.7) 27.1 (24.8e29.6) 28.2 (27.5e28.8)
Ex-smoker 21.8 (19.8e23.9) 28.2 (25.9e30.7) 20.5 (20.0e21.1)
No-smoker 53.6 (51.1e56.1) 44.5 (41.9e47.2) 51.2 (50.4e51.9)
Alcohol consumptiona Yes 23.2 (21.2e25.4) 26.5 (24.2e28.9) 26.6 (26.0e27.2)
No 76.7 (74.5e78.7) 73.4 (71.0e75.7) 73.3 (72.7e73.9)
Physical exercisea Yes 43.2 (40.8e45.6) 35.7 (33.3e38.2) 45.5 (44.7e46.1)
No 56.7 (54.3e59.1) 64.2 (61.7e66.6) 54.5 (53.8e55.2)
BMI Kg/sq.ma,b 30 22.0 (19.9e24.1) 27.5 (25.1e30.0) 15.7 (15.2e16.2)
<30 77.9 (75.8e80.0) 72.4 (69.9e74.8) 84.2 (83.7e84.7)
TOTAL 7.6 (7.3e8.0) 6.9 (6.6e7.3)
a p < 0.05 (asthmatic vs. healthy).
b p < 0.05 (having chronic bronchitis vs. healthy).
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both cases, consumption was associated with a higher score
in the variable, which indicates better mental health) were
also positive.Table 2 Prevalence of depression by socio-demographic charac
and without asthma or chronic bronchitis, and healthy individua
Spain. Adjusted by age and sex.
Variable Categories Asthm
Sex Femalea,b 10.7 (8
Maleb 3.4 (1
Age 18e49b 3.0 (1
50e59 yearsb 9.1 (4
60e69 yearsa,b 14.0 (9
70 yearsa,b 12.4 (9
Number of chronic conditions Noneb 3.6 (2
1e2a,b 11.5 (8
3b 15.1 (9
Smoking habit Smokera,b 6.1 (3
Ex-smokera,b 4.1 (2
No-smokera,b 8.2 (6
Alcohol consumption Yesb 3.1 (1
Noa,b 7.9 (6
Physical exercise Yesa,b 6.1 (4
Noa,b 8.4 (6
BMI Kg/sq.m 30a,b 9.6 (6
<30a,b 6.1 (4
TOTALa,b 7.4 (6
a p < 0.05 (asthmatic vs. healthy).
b p < 0.05 (having chronic bronchitis vs. healthy).In patients with chronic bronchitis, similar results were
obtained. Thus, the variables associated in a significant way
with “Psychological dysfunction” in these subjects were
gender, the number of chronic diseases, alcoholteristics and lifestyle variables among adults (18 years) with
ls included in the 2009 European Health interview survey for
a %(CI 95%) Chronic bronchitis
% (CI 95%)
Health % (CI 95%)
.8e12.6) 14.5 (11.9e17.1) 6.5 (6.1e7.0)
.9e5.0) 4.4 (2.6e6.2) 2.1 (1.8e2.4)
.9e4.1) 6.0 (3.6e8.4) 2.1 (1.8e2.4)
.9e13.3) 13.9 (9.1e18.7) 5.4 (4.6e6.2)
.8e18.3) 16.5 (12.2e20.8) 7.2 (6.2e8.1)
.1e15.7) 11.8 (9.1e14.6) 8.1 (7.2e9.0)
.0e5.3) 5.7 (3.6e7.9) 2.9 (2.7e3.2)
.9e14.0) 11.8 (9.5e14.1) 7.9 (7.1e8.6)
.7e20.4) 20.5 (14.9e26.2) 11.5 (8.6e14.4)
.6e8.7) 8.0 (5.2e10.8) 3.5 (3.0e4.0)
.1e6.0) 5.5 (2.7e8.4) 2.8 (2.2e3.3)
.4e10.0) 11.4 (8.7e10.1) 5.3 (4.8e5.7)
.4e4.9) 4.0 (1.8e6.2) 2.1 (1.7e2.5)
.4e9.5) 11.2 (9.1e13.4) 5.1 (4.7e5.4)
.3e7.9) 6.8 (4.7e8.8) 3.3 (3.0e3.7)
.7e10.1) 12.3 (9.9e14.8) 5.5 (5.1e5.9)
.8e12.5) 12.9 (9.2e16.6) 6.8 (5.9e7.7)
.7e7.5) 8.3 (6.5e10.1) 3.7 (3.4e4.0)
.1e8.6) 9.9 (8.3e11.5) 4.5 (4.2e4.8)
Table 3 Mean scores in positive mental health by socio-demographic characteristics and lifestyle variables among adult (18
years) with and without asthma or chronic bronchitis, and healthy individuals included in the 2009 European Health interview
survey for Spain.
Variable Categories Asthma %(CI 95%) Chronic bronchitis
% (CI 95%)
Health % (CI 95%)
Sex Femalea,b 55.3 (54.0e56.7) 50.8 (49.2e52.4) 63.2 (62.8e63.6)
Malea,b 66.7 (65.2e68.3) 61.1 (59.6e62.6) 72.3 (71.8e72.7)
Age 18e49a,b 66.7 (65.4e68.0) 61.9 (60.0e63.9) 70.7 (70.3e71.1)
50e59 yearsa,b 59.9 (56.9e63.0) 52.9 (49.9e56.0) 67.8 (67.0e68.5)
60e69 yearsa,b 56.5 (53.5e59.6) 53.9 (51.3e56.5) 67.1 (66.2e67.9)
70 yearsa,b 48.0 (45.6e50.4) 46.9 (45.0e48.8) 59.0 (58.2e59.7)
Number of chronic conditions Nonea,b 68.2 (66.9e69.6) 61.8 (60.0e63.7) 70.6 (70.2e70.9)
1e2a,b 54.3 (52.5e56.0) 52.4 (50.8e53.9) 61.6 (60.6e61.9)
3a,b 43.4 (39.5e47.3) 41.2 (37.8e44.5) 48.9 (46.6e51.2)
Smoking habit Smokera,b 63.1 (61.1e65.2) 59.1 (57.0e61.3) 69.0 (68.5e69.6)
Ex-smokera,b 63.1 (61.0e65.2) 58.1 (56.1e60.2) 69.8 (69.2e70.5)
No-smokera,b 59.1 (57.7e60.6) 54.0 (52.2e55.7) 66.3 (65.9e66.8)
Alcohol consumption Yesa,b 65.6 (63.6e67.6) 62.3 (60.3e64.3) 71.3 (70.7e71.8)
Noa,b 59.6 (58.4e60.9) 54.4 (53.0e55.7) 66.6 (66.2e66.9)
Physical exercise Yesa,b 64.5 (63.0e65.9) 60.6 (59.0e62.3) 70.4 (70.0e70.8)
Noa,b 57.3 (55.9e58.7) 52.7 (51.3e54.2) 64.7 (64.3e65.1)
BMI Kg/sq.m 30a,b 54.5 (52.1e56.9) 52.3 (50.0e54.6) 63.8 (63.0e64.6)
<30a,b 63.6 (62.4e64.8) 58.3 (56.9e59.6) 68.8 (68.5e69.1)
TOTALa,b 60.3 (59.3e61.3) 55.7 (54.6e56.8) 67.3 (67.0e67.6)
a p < 0.05 (asthmatic vs. healthy).
b p < 0.05 (having chronic bronchitis vs. healthy).
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mental health”, age and BMI also proved to be significant.
No interaction terms yield significant values in the multi-
variate analyses.Discussion
The present study demonstrates that the prevalence of
psychiatric disorders, both anxiety and depression, is
greater in patients with asthma and chronic bronchitis than
in healthy subjects. The same happens with psychological
dysfunction and positive mental health, the scores for
which are higher in healthy individuals, when compared to
those with asthma and chronic bronchitis, thus suggesting
that their mental health is much better. Among the vari-
ables associated with lower scores out of these variables,
and therefore worse mental health, are being female,
having a greater number of chronic diseases and obesity. On
the contrary, alcohol consumption and the practicing of
physical exercise are associated, generally speaking, with
a higher score in the aforementioned variables, thus indi-
cating a greater degree of mental health.
In regard to gender, it has previously been proven that
the prevalence of depression and anxiety symptoms is
higher among women. Additionally, gender can be
a predictive factor for depression, following the manifes-
tation of a primary anxiety disorder.27 Other studies have
found a high prevalence of psychiatric disorders in women
with asthma, in comparison with men who have this
disease.28,29 In this sense, it has been suggested that the
gender discrepancies in this population could be due to theexistence of different asthma phenotypes in men and
women. This hypothesis has been suggested by Sundberg
et al.,30 after detecting that women begin to show asthma
symptoms later and have a less probability of suffering from
allergic asthma. In this sense, it has been suggested that
non-allergic asthma may have a lesser response to treat-
ment with inhaled corticoids and, therefore, could be more
difficult to treat.31 In the case of COPD, it has also been
demonstrated that women have greater psychological
distress rates, as well as less perceived control over
symptoms and a greater degree of functional worsening
than men.32 In our study, we found that patients with
asthma and chronic bronchitis also have lower scores in
psychological dysfunction and positive mental health vari-
ables, when compared to healthy individuals, thus indi-
cating that their mental health is worse. The results were
even worse in women with asthma and chronic bronchitis,
compared to men with these diseases. Variables associated
with lower scores on mental health indicators in women
included the presence of comorbidities, a higher BMI and
not practice of physical exercise.
In regard to associated comorbidity, it has been previ-
ously suggested that the stress associated with the pres-
ence of chronic diseases increases the possibility of
developing a psychiatric disorder.33 In this sense, adults
with one or more chronic disorders have a greater proba-
bility of suffering from severe psychological distress than
subjects with no chronic diseases.34 Along these same lines,
Oraka et al. found that, after adjusting for all the co-
variables, adults with asthma who suffered from three or
more comorbid conditions had a significantly greater risk of
experiencing severe psychological distress.35 In this regard,
Table 4 Results of the multivariate lineal regression model to assess variables associated with psychological dysfunction and positive mental health among adults suffering
from asthma or chronic bronchitis (CB).
Variable (Reference category) Asthma Chronic bronchitis
Psychological dysfunction
R. Coefficient (CI 95%)
Positive mental health
R. Coefficient (CI 95%)
Psychological dysfunction
R. Coefficient (CI 95%)
Positive mental health
R. Coefficient (CI 95%)
Male
Age (18e49 years) 1.49 (3.25; 0.25) 2.25 (4.12; 0.39) 0.75 (0.70; 2.19) 2.36 (4.23; 0.48)
Chronic conditions (none) 5.74 (8.87; 2.60) 8.17 (11.50; 4.83) 7.12 (11.11; 3.12) 5.16 (10.30; 0.18)
Smoking habit (current smoker) 2.21 (0.33; 4.08) 2.90 (0.90; 4.89) 0.63 (1.66; 2.94) 1.02 (1.63; 3.67)
Alcohol consumption (no) 0.18 (3.00; 3.54) 1.39 (1.99; 4.77) 2.14 (1.15; 5.44) 9.94 (4.11; 15.77)
Physical exercise (no) 1.41 (1.80; 4.63) 2.74 (0.69; 6.17) 2.52 (1.02e6.07) 7.62 (3.70; 11.52)
BMI (<30 kg/sq.m) 2.19 (6.19; 1.81) 1.73 (5.99; 2.52) 0.05 (3.72; 3.82) 5.45 (9.76; 1.13)
Female
Age (18e49 years) 0.03 (1.54; 1.48) 1.43 (3.04; 0.17) 0.34 (2.16; 1.46) 1.24 (2.80; 0.32)
Chronic conditions (none) 8.82 (11.55; 6.09) 9.55 (12.44; 6.66) 6.53 (11.49; 1.57) 10.82 (15.14; 6.50)
Smoking habit (current smoker) 1.07 (0.82; 2.95) 0.89 (1.10; 2.89) 0.91 (1.65; 3.46) 0.82 (1.67; 3.31)
Alcohol consumption (no) 2.08 (1.98; 6.15) 4.59 (0.28; 8.90) 7.51 (1.88; 13.13) 3.42 (0.14; 6.98)
Physical exercise (no) 3.52 (0.70; 6.35) 3.66 (0.67; 6.66) 3.96 (0.19; 7.73) 5.41 (1.58; 9.24)
BMI (<30 kg/sq.m) 5.03 (8.44; 1.62) 6.52 (10.13; 2.91) 2.66 (6.81; 1.49) 1.52 (5.61; 2.56)
TOTAL
Sex (male) 9.10 (11.36; 6.85) 9.84 (12.24; 7.45) 9.93 (12.70; 7.15) 10.23 (13.15; 7.30)
Age (18e49 years) 0.63 (1.77; 0.50) 1.90 (3.11; 0.70) 0.24 (0.90; 1.37) 1.76 (2.96; 0.56)
Chronic conditions (none) 7.59 (9.65; 5.53) 8.93 (11.11; 6.74) 6.93 (10.08; 3.77) 8.30 (11.64; 4.96)
Smoking habit (current smoker) 1.54 (0.21; 2.86) 1.70 (0.29; 3.11) 0.52 (1.17; 2.21) 0.73 (1.05; 2.52)
Alcohol consumption (no) 1.10 (1.46; 3.66) 2.93 (0.21; 5.65) 3.79 (0.85; 6.73) 5.42 (2.31; 8.53)
Physical exercise (no) 2.68 (0.55; 4.82) 3.26 (1.00; 5.52) 3.25 (0.65; 5.84) 6.51 (3.76; 9.25)
BMI (<30 Kg/sq.m) 4.02 (6.61; 1.43) 4.89 (7.64; 2.14) 1.63 (4.43; 1.16) 3.79 (6.74; 0.83)
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930 J. de Miguel Diez et al.in our study we found a lower score in psychological
dysfunction and positive mental health variables in patients
with asthma and COPD who have associated chronic
diseases. This suggests that their mental health is worse.
However, other authors have found no relationship
between these variables.36 This has been attributed to the
overlapping between the symptoms of somatic and
psychiatric diseases, which would thus make it more diffi-
cult to detect the latter.
Obesity also has a negative influence on themental health
of patients with respiratory diseases. Thus, it has been
demonstrated, for example, that its presence, together with
psychological dysfunction, may have a predictive role in the
risk of developing asthma exacerbations.37 On the other
hand, obesity may also contribute to a decrease in the
physical activity of COPD patients. This could lead to
a deterioration of the health condition and quality of life of
these patients,38 which could contribute to a worsening of
their mental health, as demonstrated in our study.
In regard to physical activity, certain authors have observed
that chronic diseases and associated severe psychological
distress are related to frequent limitations to physical
activity.39 It has also been suggested that comorbid mental
diseases can have a negative impact on physical activity, in
people with chronic diseases, due to an increase in reactivity
against somatic symptoms, a decrease in motivation for the
care of chronic diseases, maladaptive physical effects and
somatic symptoms and a reduction in the capacity for adap-
tation.40 In our study, we have found an association between
physical exercise and higher scores in psychological dysfunc-
tion and positive mental health variables. However, the rela-
tionship between physical exercise and mental health may be
a case of reverse causation, when little exercise may result in
poorermental health, or be a result of poorermental health. A
recent study has shown that COPD patients show a lower
capacity for exercise, achieving scores that are significantly
worse on the scales of the psychiatric disorder assessment.41 In
fact, disability is a predictive factor for the development of
depressive symptoms, even among individuals who are not
initially depressed.42
It has been previously proven that the consumption of
certain substances, such as tobacco or alcohol, may be used
as a means of palliating emotional discomfort.43 In regard
to smoking, a recent study has demonstrated that a history
of smoking is associated with an increase in the risk for
depression in patients with obstructive airway diseases.44
Behavioral disorders associated with nicotine addiction
are usually accompanied by comorbid depression or
depressive symptoms,45,46 although the reasons for this
association are not fully clear. However, in our study we
found no clear association between smoking and psycho-
logical dysfunction among patients with asthma and chronic
bronchitis.
On the other hand, alcohol consumption may contribute
to masking or minimizing the degree of depression in
patients, thus, becoming an alternative strategy for facing
this problem. In this sense, a recent study has demon-
strated that alcohol abuse or dependence tends to take
place more frequently in individuals with asthma.47 In our
study, we have found a relationship between alcohol
consumption and positive mental health in patients with
asthma and chronic bronchitis, having observed thatpatients with these diseases have lower scores in this
variable than healthy individuals and, therefore, worse
mental health. However, further studies are needed to
clarify this relationship since the question used in our study
to detect alcohol consumption will probably classify alcohol
abuse, high alcohol consumption and healthy sporadic users
of alcohol as one category, since it is a very broad defini-
tion. Therefore, it is not a proper question for alcohol
abuse/dependence, which may explain the conflicting
results compared to previous studies.
The main strength of this study is the use of a repre-
sentative sample, on a national level, in order to assess the
mental health of patients with asthma and chronic bron-
chitis. There are, however, certain potential limitations
that should be taken into account. First, because it is
a cross-sectional survey, causality cannot be inferred. The
study thus does not answer whether chronic respiratory
conditions cause ill psychological health (which has been
shown) or if also the perception of somatic symptoms could
be worsened by psychological illness (which is highly likely).
Nonetheless, a series of variables independently associated
with the existence of depression or anxiety in adults with
asthma or chronic bronchitis has been identified. Secondly,
the work is based on self-reported information. Using a self
report of anxiety/depression with the criteria used in this
study is highly likely to result in under-reporting. Moreover,
the inclusion of cases treated with psychopharmacia is
likely to exclude a high number of true cases without
medical treatment. As suggested by previous studies,
anxiety and depression are often unidentified and under
treated in asthma or COPD patients. Also, certain anxiety
disorders such us generalized anxiety disorders, may be
treated with antidepressants rather than anxiolitics.
Nonetheless, although data from questionnaires are more
accurate and reliable, can be more expensive and difficult
to organize, especially in large population-based studies
like ours. On the other hand, the information that can be
obtained from the EHISS may overestimate some chronic
conditions.24 Finally, the initial response rate to the EHISS
was 64%; therefore, a possible non-response bias should be
taken into consideration.25
To conclude, this study demonstrates that patients with
asthma and chronic bronchitis have worse scores in terms of
psychological dysfunction and positive mental health vari-
ables, as compared to healthy individuals and, therefore,
worse mental health. The factors associated with worse
scores in these variables include: being female and the
existence of chronic diseases and obesity. On the contrary,
alcohol consumption and the practicing of physical exercise
were associated with better scores and, therefore, with
better mental health. Health care professionals need to be
aware of the increased risk psychological dysfunction and
mental disorders in patients with asthma or COPD. We
agree with other authors that suggest screening for mental
health disorders several times per year, perhaps at each
clinical contact, in patients with these respiratory diseases,
particularly if they are women, obese and suffer from other
associated chronic diseases while presenting limitations for
physical activity. It would be important to have longitudinal
studies in order to assess the impact of optimizing physio-
logical disorders in these subjects in terms of their mental
health and their physical activity.
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